Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Gentera. de
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Digital Initiatives And New CEO At Banco Compartamos Will Improve Future Efficiency
Key Takeaways Gentera's digital strategy and leadership changes aim to boost customer growth and earnings through improved operations and customer experience. Expansion in underbanked markets and new product offerings are expected to open revenue streams and enhance market share.
View narrative
Mex$44.36
FV
4.2% undervalued
intrinsic discount
16.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
Frequentis
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Robust Order Pipeline And Software Focus Will Secure Long-Term Success
Key Takeaways Strong order backlog and strategic shift towards software-centric models could drive significant top-line growth and enhance margins. Expanding defense market and M&A opportunities are poised to boost revenue and broaden global market presence.
View narrative
€45.55
FV
26.9% overvalued
intrinsic discount
8.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
13 days ago
author updated this narrative
EVN
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Rising Regulatory Pressures Will Challenge Renewables Despite Offsetting Efficiency Gains
Key Takeaways Heavy investment in renewables and networks supports growth, but profitability remains vulnerable to regulation, commodity price swings, and weather-driven renewable output. Expansion into digital and green infrastructure faces challenges from rising debt, limited financial flexibility, and government intervention restraining revenue potential.
View narrative
€25.00
FV
4.4% undervalued
intrinsic discount
-2.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 1 month ago
author updated this narrative
Resonac Holdings
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Legacy Chemicals Will Drag Semiconductor Prospects With Limited Upside
Key Takeaways Dependence on legacy chemicals and carbon-intensive products exposes Resonac to declining demand, margin erosion, and heightened regulatory and environmental pressures. Competitive threats, portfolio transformation challenges, and global supply chain risks threaten revenue growth, margin stability, and the ability to pivot toward higher-growth segments.
View narrative
JP¥3.30k
FV
7.9% overvalued
intrinsic discount
-5.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 1 month ago
author updated this narrative
Strategic Education
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Best Buy's All-Inclusive Degree Program Will Attract Future Students
Key Takeaways Strong enrollment growth through corporate partnerships and education technology services could drive significant revenue and earnings increases. Robust free cash flow and disciplined cost management support improved net margins and enhance shareholder returns via dividends and share repurchases.
View narrative
US$102.67
FV
24.7% undervalued
intrinsic discount
4.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
13 days ago
author updated this narrative
NZX
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Launch Of 'Dark' Will Drive Future Capital Markets Activity
Key Takeaways Successful integration and organic growth in Smartshares and Wealth Technologies signal potential for improved future revenue streams and net margins. NZX Dark's performance and strategic rollouts could boost trading revenues and enhance net margins, driving overall revenue growth.
View narrative
NZ$1.66
FV
12.7% undervalued
intrinsic discount
6.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
Updated
narrative
Wesfarmers
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Investments In Lithium And Digitization Will Position For Future Success
Key Takeaways Focused productivity initiatives and integration efforts are driving operational efficiency, reducing costs, and boosting potential earnings and margin growth across divisions. Strategic investments in lithium production and digital growth enhance long-term revenue potential and earnings, despite near-term restructuring costs.
View narrative
AU$72.97
FV
23.7% overvalued
intrinsic discount
3.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
71
users have followed this narrative
9 days ago
author updated this narrative
tinyBuild
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Data Driven Game Investments Will Secure Future Momentum
Key Takeaways Focus on cash generation and high-potential games enhances cost management and strengthens the game pipeline, boosting future revenue and earnings. Diversified revenue through own IP development and multimedia expansions supports stable growth and improved margins.
View narrative
UK£0.096
FV
34.9% undervalued
intrinsic discount
5.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
12 days ago
author updated this narrative
Bumrungrad Hospital
AN
AnalystLowTarget
Consensus Narrative from 21 Analysts
Middle Eastern Declines Will Compress Margins Yet Tech Will Assist
Key Takeaways Heavy dependence on high-spending international patients faces threats from reduced treatment intensity, evolving regulations, and stronger healthcare systems in source countries. Intensifying competition, capacity constraints, and digital healthcare alternatives may impede profitability and future revenue growth if Bumrungrad cannot further differentiate itself.
View narrative
฿150.00
FV
26.7% overvalued
intrinsic discount
2.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 1 month ago
author updated this narrative
Value any company in seconds
Popular companies